Cercar
01/09/2025
Sex-related differences in the efficacy and toxicity of cancer treatments
Bertrán, AS, Rodríguez, JAM, Cardeña-Gutiérrez, A, Martinez-Callejo, V, Higuera, O, Bernardez, B, Moreno-Martínez, ME, Majem, M. Sex-related differences in the efficacy and toxicity of cancer treatments. Clinical & Translational Oncology. 2025; 27(9)DOI:10.1007/s12094-025-03893-2. PMID:40153220. IF:2.500(Q3/6D).
26/08/2025
Opening of a phase Ib/II study to investigate the safety and efficacy of Afatinib in patients with Fanconi anemia and unresectable locally advanced or metastatic head and neck squamous cell carcinoma
Anguera, G, Gallego, O, Llobet, M, Berga, N, Moreno-Martinez, ME, Leon, X, Kratz, C, Garcia-Escudero, R, Minguillón, J, Surrallés, J. Opening of a phase Ib/II study to investigate the safety and efficacy of Afatinib in patients with Fanconi anemia and unresectable locally advanced or metastatic head and neck squamous cell carcinoma. BMC CANCER. 2025; 25(1)DOI:10.1186/s12885-025-14619-6. PMID:40859225. IF:3.400(Q2/4D).
18/08/2025
Integrating Global Surveillance, Local Action, and Innovative Stewardship Against Antimicrobial Resistance
Ruiz-Ramos, J. Integrating Global Surveillance, Local Action, and Innovative Stewardship Against Antimicrobial Resistance. Antibiotics-Basel. 2025; 14(8)DOI:10.3390/antibiotics14080835. PMID:40868029. IF:4.600(Q1/2D).
08/08/2025
The Role of Pharmacogenetic Biomarkers in Pain
da Silva, IM, Plaza-Díaz, A, Ruiz-Ramos, J, Juanes-Borrego, A, Riera, P. The Role of Pharmacogenetic Biomarkers in Pain. Biomedicines. 2025; 13(8)DOI:10.3390/biomedicines13081935. PMID:40868188. IF:3.900(Q1/3D).